Chonluten

Chonluten is a synthetic tripeptide (Glu-Asp-Gly) from the Khavinson bioregulator family, designed to act on bronchial epithelium and respiratory tract tissue. It overlaps with Bronchogen in focus area but uses a different sequence and is studied for its own profile in respiratory research. It is sold strictly for laboratory use.

Chonluten is one of two Khavinson bioregulators focused on the respiratory tract — the other being Bronchogen. Researchers study it as a small peptide signal that supports bronchial epithelium function and airway tissue maintenance. It comes up in longevity discussions for users specifically interested in respiratory health.

As a short bioregulator, Chonluten is proposed to act on tissue-specific gene expression in bronchial epithelial cells. Animal studies report normalized airway epithelium structure and reduced inflammatory markers in chronic respiratory models.

• •Bronchial epithelium regeneration
• •COPD and chronic respiratory disease models
• •Tobacco-exposure tissue damage research
• •Khavinson bioregulator family studies

Chonluten is mentioned mostly in 'full bioregulator stack' discussions on longevity forums. Direct user reports are uncommon; most knowledge comes from Russian-language literature.

“A respiratory-tissue signal in tripeptide form.”

Often paired with Bronchogen as a 'dual respiratory bioregulator' or included in a multi-organ Khavinson stack.

Chonluten is a Khavinson bioregulator tripeptide studied for bronchial epithelium and respiratory tissue maintenance. It overlaps in focus with Bronchogen and is part of the tissue-specific bioregulator family, sold for laboratory research only.